[Event Report] The 8th NIKKEI FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (October 28, 2021)
date : 11/10/2021
Tags: AMR
The 8th NIKKEI FT Communicable Diseases Conference (Host: Nikkei Inc., Co-host: The Financial Times Ltd., Tokyo Metropolitan Government) was held on October 27-28, 2021. At this event, the AMR Consortium (Secretariat: AMR Alliance Japan) of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) shared its recent activities, including the release of policy recommendations calling for the creation of a pull incentive in Japan. Members of the AMR Consortium also discussed future issues to be discussed towards better AMR policy.
In light of the situation with novel coronavirus, this conference was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.
■Overview
Event: 8th NIKKEI FT Communicable Diseases Conference
Date and time: Thursday, October 28, 2021
Relevant Agenda Item: Agenda 4- Performance of PPP from the Conference and Future Issues
■Discussion
Chairs of Nikkei FT Communicable Diseases Conference
Shigeru Omi (President, Japan Community Health care Organization (JCHO) / Regional Director Emeritus, World Health Organization (WHO), Regional Office for Western Pacific)
Nahoko Shindo (Senior Advisor, WHO Health Emergencies Programme (WHE), World Health Organization)
Discussion from AMR Consortium
Presentation (alphabetical order by last name)
Dame Sally Davies (UK Special Envoy on Antimicrobial Resistance)
Kazuhiro Tateda (President, The Japanese Society for Clinical Microbiology / Professor, Department of Microbiology and Infectious Diseases, Toho University)
Discussion (alphabetical order by last name)
Hajime Inoue (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare)
Shinichi Koguchi (Senior Stewardship Officer, Stewardship Development Department, Sumitomo Mitsui Trust Asset Management Co.,Ltd.)
Norio Ohmagari (Disease Control and Prevention Center, National Center for Global Health and Medicine (NCGM) / Director, AMR Clinical Reference Center, NCGM)
Kazumasa Oguro (Professor, Faculty of Economics, Hosei University)
Yusuke Saraya (President, Saraya Co., Ltd.)
Takuko Sawada (Director of the Board, Executive Vice President, Shionogi & Co., Ltd.)
Yasunori Tawaragi (Sustainability Promotion Department, Daiichi Sankyo Co., Ltd. / Director, AMR Incentives and Advocacy TF, Japan Pharmaceutical Manufacturers Association (JPMA))
Moderator
Ryoji Noritake (CEO, Boad Member, Health and Global Policy Institute)
■Related events held as part of the “The Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)” project in and after FY2019 (chronological order)
January 22, 2020 The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
March 11, 2020 The First Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
March 19, 2020 The Second Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
March 24, 2020 The First Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
April 27, 2020 The Second Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
July 17, 2020 The Third Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
August 18, 2020 The Second Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
August 27, 2020 The Fourth Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
September 14, 2020 The First Meeting of Working Group 3 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
September 23, 2020 The Third Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
October 7, 2020 The Fifth Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
October 8, 2020 The Third Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
November 7, 2020 The 7th NIKKEI FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC)
December 14, 2020 The Fourth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC)
March 12, 2021 The Fifth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC)
June 30, 2021 The Fourth Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
July 7, 2021 The Sixth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC)
Top Research & Recommendations Posts
- [Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
Featured Posts
-
2024-11-25
[Registration Open] (Webinar) The 130th HGPI Seminar “Marking a Decade of the Act on Medical Care for Patients With Intractable Diseases: Connecting Intractable Diseases and Society From the Perspective of a Media Professional and Family Member” (January 28, 2025)
-
2024-12-09
[Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
-
2024-12-12
[HGPI Policy Column] (No. 51) From the Planetary Health Project “Part 11: Efforts Toward Achieving Carbon Neutrality in Japan’s Pharmaceutical Industry”
-
2024-12-18
[Policy Recommendations] Policy Recommendations on Strengthening CKD Strategies for Workers: The Importance of Providing Early Detection, Intervention, and Support Through Screenings and Medical Visits (October 28, 2024)